These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

490 related articles for article (PubMed ID: 16762591)

  • 1. A longitudinal and prospective study of Epstein-Barr virus load in AIDS-related non-Hodgkin lymphoma.
    Bonnet F; Jouvencel AC; Parrens M; Leon MJ; Cotto E; Garrigue I; Morlat P; Beylot J; Fleury H; Lafon ME
    J Clin Virol; 2006 Aug; 36(4):258-63. PubMed ID: 16762591
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epstein-Barr viral load as a marker of lymphoma in AIDS patients.
    Fan H; Kim SC; Chima CO; Israel BF; Lawless KM; Eagan PA; Elmore S; Moore DT; Schichman SA; Swinnen LJ; Gulley ML
    J Med Virol; 2005 Jan; 75(1):59-69. PubMed ID: 15543571
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Absolute level of Epstein-Barr virus DNA in human immunodeficiency virus type 1 infection is not predictive of AIDS-related non-Hodgkin lymphoma.
    Van Baarle D; Wolthers KC; Hovenkamp E; Niesters HG; Osterhaus AD; Miedema F; Van Oers MH
    J Infect Dis; 2002 Aug; 186(3):405-9. PubMed ID: 12134237
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hepatitis C virus-Epstein-Barr virus interaction in patients with AIDS.
    Challine D; Buisson M; Cadilhac M; Germanidis G; Joab I; Eliaszewicz M; Caumes E; Flahault A; Fillet AM; Pawlotsky JM; Seigneurin JM
    J Med Virol; 2002 Aug; 67(4):510-5. PubMed ID: 12115996
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quantification of Epstein-Barr virus load in peripheral blood of human immunodeficiency virus-infected patients using real-time PCR.
    Dehee A; Asselot C; Piolot T; Jacomet C; Rozenbaum W; Vidaud M; Garbarg-Chenon A; Nicolas JC
    J Med Virol; 2001 Nov; 65(3):543-52. PubMed ID: 11596092
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epstein-Barr virus load and immune activation in human immunodeficiency virus type 1-infected patients.
    Petrara MR; Cattelan AM; Zanchetta M; Sasset L; Freguja R; Gianesin K; Cecchetto MG; Carmona F; De Rossi A
    J Clin Virol; 2012 Mar; 53(3):195-200. PubMed ID: 22209290
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ganciclovir is associated with low or undetectable Epstein-Barr virus DNA load in cerebrospinal fluid of patients with HIV-related primary central nervous system lymphoma.
    Bossolasco S; Falk KI; Ponzoni M; Ceserani N; Crippa F; Lazzarin A; Linde A; Cinque P
    Clin Infect Dis; 2006 Feb; 42(4):e21-5. PubMed ID: 16421782
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Circulating Epstein-Barr virus (EBV) in HIV-infected patients and its relation with primary brain lymphoma.
    Fellner MD; Durand K; Correa RM; Redini L; Yampolsky C; Colobraro A; Sevlever G; Teyssié AR; Benetucci J; Picconi MA
    Int J Infect Dis; 2007 Mar; 11(2):172-8. PubMed ID: 16931088
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epstein-Barr virus and human immunodeficiency virus serological responses and viral burdens in HIV-infected patients treated with HAART.
    O'Sullivan CE; Peng R; Cole KS; Montelaro RC; Sturgeon T; Jenson HB; Ling PD
    J Med Virol; 2002 Jul; 67(3):320-6. PubMed ID: 12116021
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of variants in the promoter of EBV gene BZLF1 in normal donors, HIV-positive patients and in AIDS-related lymphomas.
    Martini M; Capello D; Serraino D; Navarra A; Pierconti F; Cenci T; Gaidano G; Larocca LM
    J Infect; 2007 Mar; 54(3):298-306. PubMed ID: 16784778
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Assessment of automated DNA extraction coupled with real-time PCR for measuring Epstein-Barr virus load in whole blood, peripheral mononuclear cells and plasma.
    Fafi-Kremer S; Brengel-Pesce K; Barguès G; Bourgeat MJ; Genoulaz O; Seigneurin JM; Morand P
    J Clin Virol; 2004 Jun; 30(2):157-64. PubMed ID: 15125872
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quantitation of whole blood Epstein-Barr virus DNA is useful for assessing treatment response in patients with non-Hodgkin's lymphoma.
    Jo SA; Hwang SH; Kim SY; Shin HJ; Chung JS; Sol MY; Chang CL; Lee EY
    Int J Lab Hematol; 2010 Feb; 32(1 Pt 1):e106-13. PubMed ID: 19522857
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epstein-Barr virus DNA load in cerebrospinal fluid and plasma of patients with AIDS-related lymphoma.
    Bossolasco S; Cinque P; Ponzoni M; Vigano MG; Lazzarin A; Linde A; Falk KI
    J Neurovirol; 2002 Oct; 8(5):432-8. PubMed ID: 12402169
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Assessment of immunovirological features in HIV related non-Hodgkin lymphoma patients and their impact on outcome.
    Tedeschi R; Bortolin MT; Bidoli E; Zanussi S; Pratesi C; Vaccher E; Tirelli U; De Paoli P
    J Clin Virol; 2012 Apr; 53(4):297-301. PubMed ID: 22244256
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epstein-Barr virus-specific cytotoxic T cell responses in HIV-1 infection: different kinetics in patients progressing to opportunistic infection or non-Hodgkin's lymphoma.
    Kersten MJ; Klein MR; Holwerda AM; Miedema F; van Oers MH
    J Clin Invest; 1997 Apr; 99(7):1525-33. PubMed ID: 9119996
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Aberrant Epstein-Barr virus persistence in HIV carriers is characterized by anti-Epstein-Barr virus IgA and high cellular viral loads with restricted transcription.
    Stevens SJ; Smits PH; Verkuijlen SA; Rockx DA; van Gorp EC; Mulder JW; Middeldorp JM
    AIDS; 2007 Oct; 21(16):2141-9. PubMed ID: 18090040
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Plasma EBV-DNA monitoring in Epstein-Barr virus-positive Hodgkin lymphoma patients.
    Spacek M; Hubacek P; Markova J; Zajac M; Vernerova Z; Kamaradova K; Stuchly J; Kozak T
    APMIS; 2011 Jan; 119(1):10-6. PubMed ID: 21143522
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Plasma Epstein-Barr virus (EBV) DNA is a biomarker for EBV-positive Hodgkin's lymphoma.
    Gandhi MK; Lambley E; Burrows J; Dua U; Elliott S; Shaw PJ; Prince HM; Wolf M; Clarke K; Underhill C; Mills T; Mollee P; Gill D; Marlton P; Seymour JF; Khanna R
    Clin Cancer Res; 2006 Jan; 12(2):460-4. PubMed ID: 16428487
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Blood Epstein-Barr virus DNA load and risk of progression to AIDS-related systemic B lymphoma.
    Leruez-Ville M; Seng R; Morand P; Boufassa F; Boue F; Deveau C; Rouzioux C; Goujard C; Seigneurin JM; Meyer L
    HIV Med; 2012 Sep; 13(8):479-87. PubMed ID: 22414000
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A longitudinal and cross-sectional study ofEpstein-Barr virus DNA load: a possible predictor of AIDS-related lymphoma in HIV-infected patients.
    Hijlkema SH; van Kampen JJA; Voermans JJC; den Oudsten MYE; Doorduijn J; van Lugtenburg PJ; van de Vijver DAMC; van der Ende ME
    Infect Dis (Lond); 2018; 50(11-12):847-852. PubMed ID: 30317893
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.